Do you like AGIX here? If they've got a great diabetes drug in Phase III with $130 million in cash and a $95 million market cap, they would seem to be pretty intriguing. You always say that you like to buy stocks when they are out of favor.
black-box warnings will soon be added to Avandia, Actos, and perhaps other diabetes meds
I doubt that in the end there will be a black box for Actos - since they have a randomized trial in cardiac endpoints that was successful for showing that Actos reduced cardiac events. (I know that in some of the Avandia discussions in the Press there has been talk of Actos being similar to Avandia - but unless I missed something quite large in the Actos trial this seems very unlikely.)
Market Data 
Markets 
AI
